BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18325677)

  • 1. Acticoat: a critique of application.
    Burd A; Chiu T; Huang L
    Burns; 2008 Jun; 34(4):575-7; author reply 578-9. PubMed ID: 18325677
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective cohort study of Acticoat versus Silvazine in a paediatric population.
    Cuttle L; Naidu S; Mill J; Hoskins W; Das K; Kimble RM
    Burns; 2007 Sep; 33(6):701-7. PubMed ID: 17644258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
    Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q
    Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
    Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
    J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Acticoat dressings in burns: what is the evidence?
    Khundkar R; Malic C; Burge T
    Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acticoat dressings and major burns: systemic silver absorption.
    Moiemen NS; Shale E; Drysdale KJ; Smith G; Wilson YT; Papini R
    Burns; 2011 Feb; 37(1):27-35. PubMed ID: 20961690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acticoat and smith and nephew.
    Burd A
    Burns; 2012 Feb; 38(1):142; author reply 143. PubMed ID: 22103984
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
    Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
    Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing at home: Comparing cohorts of children with medium-sized burns treated as outpatients with in-hospital applied Acticoat to those children treated as inpatients with silver sulfadiazine.
    Peters DA; Verchere C
    J Burn Care Res; 2006; 27(2):198-201. PubMed ID: 16566565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department.
    Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M
    J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Our experience in using the air-bag technic in the treatment of burns of the hands].
    Mugea T; Jecan R
    Chirurgia (Bucur); 1995; 44(3):47-53. PubMed ID: 8624451
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical experience of treating exfoliative wounds using nanocrystalline silver-containing dressings (Acticoat).
    Yang JY; Huang CY; Chuang SS; Chen CC
    Burns; 2007 Sep; 33(6):793-7. PubMed ID: 17532147
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
    Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B
    Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocrystalline silver (Acticoat) for itch relief in the burns patient.
    Brooks P; Phang KL; Moazzam A
    ANZ J Surg; 2007 Sep; 77(9):797. PubMed ID: 17685964
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing Suprathel®-therapy by the use of Octenidine-Gel®.
    Radu CA; Gazyakan E; Germann G; Riedel K; Reichenberger M; Ryssel H
    Burns; 2011 Mar; 37(2):294-8. PubMed ID: 21075536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and management of wound infection: the role of silver.
    Stephen-Haynes J; Toner L
    Br J Community Nurs; 2007 Mar; 12(3):S6, S8, S10-2. PubMed ID: 17505354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suprathel-acetic acid matrix versus acticoat and aquacel as an antiseptic dressing: an in vitro study.
    Ryssel H; Germann G; Riedel K; Reichenberger M; Hellmich S; Kloeters O
    Ann Plast Surg; 2010 Oct; 65(4):391-5. PubMed ID: 20798627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flamazine is not a debriding agent.
    Kelly J
    Br J Nurs; 2001 Aug 9-Sep 12; 10(15):967. PubMed ID: 11942317
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of Acticoat in neonatal burns.
    Rustogi R; Mill J; Fraser JF; Kimble RM
    Burns; 2005 Nov; 31(7):878-82. PubMed ID: 16029933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.